StockWatch
·
SUPRAJIT ENGINEERING · Q2 FY27 · THE VERDICT

Revenue surges 21%, profit crawls at 5%—the operating leverage broke

A quarter of stark contrast: Suprajit delivered robust 20.6% topline growth and reaffirmed FY27 guidance, but net profit grew only 4.7%. The gap between headline momentum and profit delivery is the story—and it's dragging the stock down from its all-time high.

Q2 FY27 resultsSUPRAJITSUPRAJIT ENGINEERING LTD.-$17 Nov 2026 · 6 min read
Q2 Revenue

₹1,135 Cr

+20.6% YoY

Q2 Net profit

₹53.4 Cr

+4.7% YoY (vs ₹49.7 Cr)

Net profit margin

4.7%

compressed vs historical

Stock price

₹445

−30.4% from ATH ₹639.6

On paper, Suprajit's topline story is clean: 20.6% YoY growth, H1 revenue at ₹2,205 Cr, EBITDA up 40%. All divisions recovering—GCM margins jumped from 7.4% to 10%+, ICM bounced 12.8% to 15.3%. And management reaffirmed the FY27 guidance of 12–13.5% consolidated EBITDA margin without blink. Yet the profit line tells a different story. PAT grew only 4.7% YoY—meaning Suprajit captured ₹234 Cr of new revenue but let only ₹2.4 Cr flow to the bottom line. That gap, and what it reveals, is the real quarter.

Where profit went

The culprit is a combination of three headwinds, none one-time but all material. First, the tax rate: H1 effective rate came in at 34.5%, well above the FY27 guidance of 27–28%. CFO Ajith Kumar Rai attributed this to deferred tax assets overseas that will normalize over time, but the near-term impact is real—a tax rate 6–7 percentage points above guidance is worth ₹8–10 Cr of profit drag on a ₹60 Cr PAT base. Second, high D&A from capex: Suprajit is mid-stride in a ₹200 Cr capex program (Suprajit Automotive greenfield in Chennai, SED facility expansion). Half is done by H1, so depreciation is rising, compressing EBITDA-to-PAT conversion. Third, operating expense deleveraging: despite 20.6% topline growth, operating expenses (selling, general, admin) haven't scaled down proportionally, suggesting cost inflation (wages, logistics, component sourcing) is eating operating leverage.

Q2 FY27 growth, %
014.9329.8744.820.6Revenue40EBITDA4.7PAT
Operating leverage broken: revenue +20.6%, PAT +4.7%. Tax burden and capex D&A account for the compression.
Management claims vs. what holds up

FY27 double-digit consolidated revenue growth

Delivered

H1: 22% YoY; Q2: 20.6% YoY; on track

Verdict

Supported ✓

EBITDA margin 12–13.5% maintained

Delivered

H1 margin 12.1% (lower end of range); reaffirmed

Verdict

Supported ✓

GCM 10–12% operational margin intact

Delivered

Q2 at 10%+ (up from 7.4% Q1); within target

Verdict

Supported ✓

ICM/PLE/SED all recovering post wage pass-through

Delivered

ICM 15.3% (Q2 vs 12.8% Q1); PLE 14.4%; SED 50%+ QoQ growth but margin pressure

Verdict

Partially supported; SED margin recovery timeline unclear

H2 margins expected slightly better than H1

Delivered

Forward-looking guidance; not yet verified

Verdict

Plausible but unverified; commodity/macro remain uncertain

What changed on this call

Three material shifts from Q1:

  • GCM margin recovery 7.4%→10%+ (Q1→Q2)

  • ICM margin bounce 12.8%→15.3% with OEM cable +20% growth

  • Europe market outlook downgraded; marquee customer volumes halved (500k→300–400k sets/year)

  • SED 50%+ QoQ growth but component cost inflation flagged as margin 'challenge'

  • PAT growth underperformance (+4.7% YoY) signals profit-quality headwind

On strategy, Suprajit detailed the new product pipeline: Ultraviolette e-bike displays ramping, TFT cluster products entering production, brake systems (combi-brake, CBS) moving to commercial launch in Q3. These are real TAM expanders for SED, but margin recovery remains near-term risk. Meanwhile, GCM's China EV OEM ramp (20–22 projects with 'largest EV maker') is becoming material—management noted Chinese orders as a source of 'very strong' traction. The U.S. business also showed uplift, moving from near-zero base to 'fairly strong' growth. This geographic diversification is offsetting Europe's structural decline, but the Europe weakness is now openly flagged as a medium-term concern, not a temporary blip.

The bull-bear ledger

What is working
  • Revenue +22% in H1 on broad-based growth (all segments positive)

  • GCM and ICM margins recovering on pricing power and cost control

  • FY27 guidance held at 12–13.5% EBITDA margin; management confidence intact

  • Capex 50% complete; Suprajit Auto greenfield, SED facility on track for H2 payoff

  • LDC actuator acquisition tech leverage; EV OEM partnerships (Ultraviolette, Royalfield, Flying Flea) validating platform

  • Net debt ₹371 Cr (down from ~₹400 Cr); FCF generation supporting 30–40% payout + debt reduction

What demands watching
  • PAT growth +4.7% vs revenue +20.6%—operating leverage broken; tax rate 34.5% (vs 27-28% guidance) artificially depressing

  • NPM compressed to 4.7%; prior periods sustained higher margins; profit-quality concern

  • Europe market weakness structural; customer volumes halved (500k→300–400k sets/year); offset by U.S./China but risk material

  • SED component cost inflation from imported electronics; pass-through delayed 'more time than expected'

  • GCM China EV OEM concentration risk; 20–22 projects with single/few OEMs; policy/subsidy changes could disrupt ramp

  • Capex execution risk; ₹200 Cr greenfield projects (Suprajit Auto, SED facility) in construction; delays/overruns could impact FCF

Ranked risks

Concerns, ordered by severity for a holder

Profit-quality deterioration

High

PAT +4.7% YoY vs revenue +20.6% signals weak operating leverage. Tax rate 34.5% (vs 27-28% guidance) and rising D&A from capex are depressing organic profit delivery. Even with tax normalization, profit growth will likely remain in low-to-mid single digits if operational deleveraging persists.

Electronics (SED) margin volatility

Medium

Component cost inflation from imported chips (Qualcomm, etc.) is limiting price pass-through. 50%+ QoQ growth masks margin dips. Recovery timeline uncertain ('more time than expected'). Near-term earnings risk if pass-through fails or customer mix shifts to lower-margin products.

Europe auto market structural slowdown

Medium

GCM's marquee German customer halved volumes (500k→300–400k sets/year). Described as 'slow and weak' with no near-term recovery signaled. While U.S. and China growth offsets, Europe risk is material to FY27 margin guidance if volume declines accelerate or others follow suit.

Capex execution and payoff timing

Medium

₹200 Cr capex (Suprajit Auto greenfield, SED facility expansion) is 50% complete by H1. Delays in construction, cost overruns, or weaker-than-expected capacity utilization could impact FCF generation and derail 30–40% payout + debt reduction plan. D&A also drags near-term PAT.

China EV OEM concentration

Medium

GCM's fastest growth vector (20–22 projects with 'largest EV maker'). Thin management disclosure on diversification within China suggests customer/OEM concentration risk. Policy shifts (subsidy changes, trade) or competitive loss could disrupt the ramp and derail FY27 growth guidance.

How the street is positioned

Suprajit's stock is down 30.4% from its all-time high of ₹639.6, trading at ₹445.15 as of November 17. It is below all three major moving averages (SMA20 ₹466, SMA50 ₹472, SMA200 ₹459)—a bearish technical setup. RSI at 36.8 is neutral/slightly oversold, suggesting limited near-term downside momentum but no strong buy signal. Volume trend is increasing, which could indicate accumulation, but the price action is largely defensive. From its 52-week low of ₹389.95, the stock is off lows by 14.16%, suggesting some stabilization bid, though well-removed from highs.

Ownership flows tell a nuanced story: FII ownership ticked up 66 basis points QoQ to 7.20% (from 6.54% in Q1 FY27), suggesting modest institutional buying despite the 30% drawdown. DII holdings fell slightly (−57 bps) to 16.44%. Promoter holding stable at 45.26%. The FII uptick is small but notable—institutions are selectively adding into the weakness, possibly viewing the drawdown as excessive given the fundamental revenue traction. However, DII trimming and the broad equity pullback in Indian auto stocks (EV transition volatility) have outweighed that institutional bid.

The valuation drawdown (−30% from ATH) is consistent with a re-rating driven by profit-quality concerns. Market is repricing Suprajit on the broken operating leverage (PAT lag) and macro headwinds (Europe, component cost inflation, China subsidy uncertainty). The gap between headline revenue growth and profit delivery has not gone unnoticed. At current prices, the stock reflects skepticism on near-term profit delivery, though the FII accumulation suggests some see the capex payoff and margin recovery as a medium-term re-rating opportunity once tax normalization and capex D&A ease.

What to watch next
  • 1 · Q3 organic PAT run-rate and tax rate normalization

    The key measure: reported PAT excluding the 34.5% tax drag. If tax rate normalizes toward 27–28% guidance in Q3, it will unlock ₹8–10 Cr of profit. If it remains elevated, profit-quality concern deepens. Also watch for capex D&A trend—does it plateau or accelerate? This will determine whether operating leverage recovers.

  • 2 · SED component cost pass-through progress

    Management cited pass-through 'taking more time than expected.' Concrete evidence of pricing power recovery in SED (margin improvement, customer order flow) will validate the near-term margin recovery narrative. If pass-through continues to lag, SED profitability remains a headwind and FY27 margin guidance at risk.

  • 3 · Europe auto market stabilization vs. further decline

    GCM's marquee German customer halved volumes (500k→300–400k sets/year). Watch for Q3 commentary on whether this is stabilizing or continuing to slide, and whether U.S./China growth can fully offset. If Europe volumes decline further, FY27 guidance (12–13.5% EBITDA margin) will face pressure.

  • 4 · Capex payoff and capacity utilization ramp

    Suprajit Auto greenfield (Chennai cable plant) and SED facility expansion should be nearing completion by H2 FY27. Watch for new capacity coming online, margins improving, and D&A plateau signaling capex cycle end. This is the medium-term catalyst for profit re-rating if realized.

Suprajit is executing a steady turnaround: revenue growth is real, division margins are recovering, and capex investments in SED and auto actuators are positioning it for EV content expansion. FY27 guidance is reaffirmed and credible. But this is NOT a quarter of step-change profit delivery. The operating leverage broke in Q2—profit grew 4.7% while revenue grew 20.6%—and near-term headwinds (tax rate 34.5%, capex D&A, component cost inflation, Europe weakness) will suppress PAT growth through H2. The street's repricing (down 30% from ATH) reflects this skepticism, and it is justified.

The margin recovery and capex payoff are real, but 12–18 months out. For now, the fundamental case hinges on a single metric: organic PAT growth excluding tax and capex D&A headwinds. If that number re-accelerates to mid-teens% by Q4 or Q1 FY28, the stock will re-rate higher. If profit growth remains stuck in low-single digits, the drawdown has further to go. Watch Q3's organic run-rate closely—that is the number that resolves the debate.

Informational and educational content only. Not investment advice.